James E. Thompson
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Cancer Research top 2%
- NF-κB Signaling Pathways
Papers in
-
- Melanoma and MAPK Pathways 11
- Histone Deacetylase Inhibitors Research 9
- Hematology 54
- Acute Myeloid Leukemia Research 39
- Chronic Myeloid Leukemia Treatments 22
- Co-authors
- Stephen C. Fry (4 shared papers)Sankar Ghosh (1 shared paper)Paul Tempst (1 shared paper)Hediye Erdjument‐Bromage (1 shared paper)Ronald T. Raines (4 shared papers)Craig B. Thompson (1 shared paper)Eunice S. Wang (40 shared papers)Dean Sheppard (7 shared papers)
- Journals
- Blood (25 papers)Bioorganic & Medicinal Chemistry Letters (12 papers)Leukemia Research (7 papers)Biochemistry (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
James E. Thompson
135 papers receiving 4.4k citations
James E. Thompson's Hit Papers
Peers
Comparison fields: 5 of 165
- Hematology 613
- Cancer Research 658
- Immunology 716
- Molecular Biology 2.2k
- Genetics 306
Countries citing papers authored by James E. Thompson
This map shows the geographic impact of James E. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Thompson more than expected).
Fields of papers citing papers by James E. Thompson
This network shows the impact of papers produced by James E. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Thompson. The network helps show where James E. Thompson may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IκB-β regulates the persistent response in a biphasic activation of NF-κB Hit paper breakdown → | 1995 | 691 |
| 2 | 2001 | 229 | |
| 3 | 2002 | 224 | |
| 4 | 2004 | 171 | |
| 5 | 2000 | 145 | |
| 6 | 2001 | 142 | |
| 7 | 2000 | 129 | |
| 8 | 2005 | 128 | |
| 9 | 1981 | 123 | |
| 10 | 1994 | 112 | |
| 11 | 1994 | 106 | |
| 12 | 2005 | 106 | |
| 13 | 2018 | 97 | |
| 14 | 1988 | 95 | |
| 15 | 1987 | 91 | |
| 16 | 2012 | 89 | |
| 17 | 2009 | 87 | |
| 18 | 2010 | 83 | |
| 19 | 2011 | 82 | |
| 20 | 1995 | 73 |
About James E. Thompson
James E. Thompson is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Organic Chemistry, having authored 148 papers that have together received 4.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (39 papers), Chronic Myeloid Leukemia Treatments (22 papers), Melanoma and MAPK Pathways (11 papers), Acute Lymphoblastic Leukemia research (10 papers), Chronic Lymphocytic Leukemia Research (10 papers), Histone Deacetylase Inhibitors Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Asthma and respiratory diseases (7 papers). The work is most often cited by research in Hematology (613 citations), Cancer Research (658 citations), Immunology (716 citations), Molecular Biology (2.2k citations) and Genetics (306 citations). James E. Thompson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Stephen C. Fry, Sankar Ghosh, Paul Tempst, Hediye Erdjument‐Bromage, Ronald T. Raines, Craig B. Thompson, Eunice S. Wang, Dean Sheppard, Martin Carroll and Meir Wetzler. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Leukemia Research, Biochemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.